Literature DB >> 25501264

Functional expression of the Fc-fused extracellular domains of group II membrane proteins.

Weicheng Wu1, Jing Jin, Xiaojuan Liu, Yufei Zhang, Meng Li, Miaomiao Shao, Yifan Qian, Dongmei Zhang, Haiyan Zhu, Yuanyuan Ruan, Jianhui Xie, Jianxin Gu.   

Abstract

The complicated delivery mechanism of group II membrane proteins makes it difficult to decide the fusion pattern of their extracellular domains (ECDs) with Fc moiety. In this study, we compared the expression of ECDs of three group II membrane proteins including CLEC-2, Dectin-1, and LOX-1 by fusion of Fc moiety. We found that the pattern of ECD-Fc fusion order produced the functionally active recombinant proteins while the pattern of Fc-ECD fusion order led to the altered glycosylation which abolished the binding of these proteins with their ligands. Meanwhile, our results indicated that the secretion of mouse Fc (mFc)-fused ECD of CLEC-2 was more efficient than that of rabbit Fc (rFc)-fused protein, while rFc moiety was more sensitive for detection compared with mFc moiety. Altogether, we provide a favorable fusion pattern of Fc moiety with the ECDs of group II transmembrane proteins.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25501264     DOI: 10.1007/s10719-014-9571-5

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  19 in total

Review 1.  C-type lectin receptors on dendritic cells and Langerhans cells.

Authors:  Carl G Figdor; Yvette van Kooyk; Gosse J Adema
Journal:  Nat Rev Immunol       Date:  2002-02       Impact factor: 53.106

2.  An efficient delivery of DAMPs on the cell surface by the unconventional secretion pathway.

Authors:  Haiyan Zhu; Lan Wang; Yuanyuan Ruan; Lei Zhou; Dongmei Zhang; Zhihui Min; Jianhui Xie; Min Yu; Jianxin Gu
Journal:  Biochem Biophys Res Commun       Date:  2010-12-17       Impact factor: 3.575

Review 3.  Making the most of affinity tags.

Authors:  David S Waugh
Journal:  Trends Biotechnol       Date:  2005-06       Impact factor: 19.536

Review 4.  Optimal and consistent protein glycosylation in mammalian cell culture.

Authors:  Patrick Hossler; Sarwat F Khattak; Zheng Jian Li
Journal:  Glycobiology       Date:  2009-06-03       Impact factor: 4.313

Review 5.  Protein-glycan interactions in the control of innate and adaptive immune responses.

Authors:  Yvette van Kooyk; Gabriel A Rabinovich
Journal:  Nat Immunol       Date:  2008-06       Impact factor: 25.606

6.  Multiple mechanisms of protein insertion into and across membranes.

Authors:  W T Wickner; H F Lodish
Journal:  Science       Date:  1985-10-25       Impact factor: 47.728

Review 7.  Novel platelet activation receptor CLEC-2: from discovery to prospects.

Authors:  K Suzuki-Inoue; O Inoue; Y Ozaki
Journal:  J Thromb Haemost       Date:  2011-07       Impact factor: 5.824

8.  Importance of neonatal FcR in regulating the serum half-life of therapeutic proteins containing the Fc domain of human IgG1: a comparative study of the affinity of monoclonal antibodies and Fc-fusion proteins to human neonatal FcR.

Authors:  Takuo Suzuki; Akiko Ishii-Watabe; Minoru Tada; Tetsu Kobayashi; Toshie Kanayasu-Toyoda; Toru Kawanishi; Teruhide Yamaguchi
Journal:  J Immunol       Date:  2010-01-18       Impact factor: 5.422

Review 9.  Expression systems for therapeutic glycoprotein production.

Authors:  Yves Durocher; Michael Butler
Journal:  Curr Opin Biotechnol       Date:  2009-11-04       Impact factor: 9.740

Review 10.  Myeloid C-type lectins in innate immunity.

Authors:  Matthew J Robinson; David Sancho; Emma C Slack; Salomé LeibundGut-Landmann; Caetano Reis e Sousa
Journal:  Nat Immunol       Date:  2006-12       Impact factor: 25.606

View more
  1 in total

1.  Extracellular Fibrinogen-binding Protein (Efb) from Staphylococcus aureus Inhibits the Formation of Platelet-Leukocyte Complexes.

Authors:  Mareike G Posner; Abhishek Upadhyay; Aisha Alsheikh Abubaker; Tiago M Fortunato; Dina Vara; Ilaria Canobbio; Stefan Bagby; Giordano Pula
Journal:  J Biol Chem       Date:  2015-12-01       Impact factor: 5.157

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.